by Support | Feb 3, 2020 | Featured, News, Research
A new study adds support to claims that the psychedelic drug psilocybin, when combined with psychotherapy, can effectively treat depression and anxiety years after taking the drug. The research follows up on a 2016 study that tested the effects of a single-dose,...
by Support | Jan 27, 2020 | Research
Ego‐disturbances have been a topic in schizophrenia research since the earliest clinical descriptions of the disorder. Manifesting as a feeling that one’s “self,” “ego,” or “I” is disintegrating or that the border between one’s self and the external world...
by Support | Jan 25, 2020 | Research
Perturbing a system and observing the consequences is a classic scientific strategy for understanding a phenomenon. Psychedelic drugs perturb consciousness in a marked and novel way and thus are powerful tools for studying its mechanisms. In the present analysis, we...
by Support | Jan 22, 2020 | News, Research
The research team found that people who recently took psychedelics such as LSD and psilocybin, more commonly known as magic mushrooms, were more likely to report having “transformative experiences” so profound that they came out of the experience radically changed....
by Support | Dec 17, 2019 | News, Research
More than 264 million people worldwide are affected by depression, according to the World Health Organization. The most common pharmaceutical treatment is to take antidepressants like Prozac, which increase levels of serotonin in the brain to improve mood. But this...
by Support | Nov 27, 2019 | News, Research
FDA official designated Ursona Institute’s phase 2 clinical trials using psilocybin to treat depression in 80 patients Breakthrough Therapy status Wednesday The psychoactive chemical comes from ‘magic mushrooms’ and has now been given...
